Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
( , , , ..) 10
Kate Daniel Author Ferhatbegovi L et al
The pivotal SURPASS clinical trial program for type 2 diabetes enrolled over 10,000 participants across multiple international sites, demonstrating tirzepatide's efficacy across a range of baseline characteristics and disease severities
The Wegovy FDA label mentions acute kidney injury and worsening of chronic renal failure in patients taking GLP-1 receptor agonists, even sometimes requiring hemodialysis
US$ 20.78
US$ 21.00
US$ 23.94
US$ 23.90
US$ 23.21
US$ 29.61
US$ 21.08
US$ 23.64
US$ 22.48
US$ 20.55
US$ 27.65
US$ 24.80
US$ 29.04
US$ 21.61
US$ 24.98
-600x315w.jpg)
US$ 21.82
US$ 20.89
